Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (31-40 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1996
Pharmacology of the low-molecular-weight heparinsJ Fareed, D A Hoppensteadt
Thrombosis Research|December 1, 1987
The effect of molecular weight on the bioavailability of heparinR M Emanuele, J Fareed
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor/tissue factor pathway inhibitorJ Fareed, J L Francis
Thrombosis Research|June 1, 1995
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapyD D Callas, J Fareed
JAMA|July 28, 1978
Antithrombin III assaysH L Messmore, J Fareed
Circulation|December 31, 1997
Plasma thrombomodulin level as a predictor of hemorrhagic (and thrombotic) events in patients on long-term anticoagulant treatmentJ Fareed, H L Messmore
Clinics in Laboratory Medicine|December 1, 1994
Automation and quality control in the coagulation laboratoryJ M Walenga, J Fareed
Thrombosis Research|June 15, 1986
Heparin-induced platelet aggregation: dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractionsL D Brace, J Fareed
International Angiology : a Journal of the International Union of Angiology|May 28, 2011
Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinuxD Welzel, R Hull, J Fareed
Acta Radiologica: Diagnosis|January 1, 1982
Contrast media induced serotonin release in human bloodZ Parvez, R Moncada, J Fareed
Pageof 39

Showing results (31-40 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|January 1, 1996
Pharmacology of the low-molecular-weight heparinsJ Fareed, D A Hoppensteadt
Thrombosis Research|December 1, 1987
The effect of molecular weight on the bioavailability of heparinR M Emanuele, J Fareed
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor/tissue factor pathway inhibitorJ Fareed, J L Francis
Thrombosis Research|June 1, 1995
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapyD D Callas, J Fareed
JAMA|July 28, 1978
Antithrombin III assaysH L Messmore, J Fareed
Circulation|December 31, 1997
Plasma thrombomodulin level as a predictor of hemorrhagic (and thrombotic) events in patients on long-term anticoagulant treatmentJ Fareed, H L Messmore
Clinics in Laboratory Medicine|December 1, 1994
Automation and quality control in the coagulation laboratoryJ M Walenga, J Fareed
Thrombosis Research|June 15, 1986
Heparin-induced platelet aggregation: dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractionsL D Brace, J Fareed
International Angiology : a Journal of the International Union of Angiology|May 28, 2011
Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinuxD Welzel, R Hull, J Fareed
Acta Radiologica: Diagnosis|January 1, 1982
Contrast media induced serotonin release in human bloodZ Parvez, R Moncada, J Fareed
Pageof 39